Budesonide metered dose inhalers (Pulmicort®) will be replaced with CFC free versions at the end of the year. The manufacturer has advised healthcare professionals that the lowest dose (50 micrograms/actuation) will no longer be available and will be replaced by a higher strength (100 micrograms/actuation).
It is advised that patients currently taking the 50 microgram product at a dose of two puffs twice daily can be moved onto the new product however patients currently taking the lowest daily dose will require a review and perhaps an alternative treatment.
Action: Clinicians should be aware of this announcement. Patients currently using the affected product would benefit from a brief intervention to advise about the product change and to discuss alternatives.
|« Aspirin in diabetes||Poor diet contributes 30% to MI risk »|